Literature DB >> 26108999

Multifaceted roles of HSF1 in cancer.

Sufang Jiang1, Kailing Tu, Qiang Fu, David C Schmitt, Lan Zhou, Na Lu, Yuhua Zhao.   

Abstract

Heat shock transcription factor 1 (HSF1) is the master regulator of the heat shock response. Accumulating evidence shows that HSF1 is overexpressed in a variety of human cancers, is associated with cancer aggressiveness, and could serve as an independent diagnostic or prognostic biomarker. In this review, we will provide an overview of the multifaceted roles of HSF1 in cancer, with a special focus on the four underlying molecular mechanisms involved. First, HSF1 regulates the expression of heat shock proteins (HSPs) including HSP90, HSP70, and HSP27. Second, HSF1 regulates cellular metabolism, including glycolysis and lipid metabolism. Third, HSF1 serves as a regulator of different signaling pathways, such as HuR-HIF-1, Slug, protein kinase C (PKC), nuclear factor-kappaB (NF-κB), PI3K-AKT-mTOR, and mitogen-activated protein kinase (MAPK) pathways. Finally, HSF1 regulates microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). Overall, HSF1 plays many important roles in cancer via regulating cell proliferation, anti-apoptosis, epithelial-mesenchymal transition (EMT), migration, invasion, and metastasis and may be a potential therapeutic target for human cancers.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26108999     DOI: 10.1007/s13277-015-3674-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  74 in total

1.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

2.  The proto-oncogene JUN is a target of the heat shock transcription factor HSF1.

Authors:  Maki Sawai; Yukio Ishikawa; Azumi Ota; Hiroshi Sakurai
Journal:  FEBS J       Date:  2013-11-05       Impact factor: 5.542

Review 3.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

Review 4.  Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications.

Authors:  Daniel R Ciocca; Francisco E Gago; Mariel A Fanelli; Stuart K Calderwood
Journal:  J Steroid Biochem Mol Biol       Date:  2006-10-17       Impact factor: 4.292

5.  The SLUG zinc-finger protein represses E-cadherin in breast cancer.

Authors:  Karen M Hajra; David Y-S Chen; Eric R Fearon
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

6.  HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins.

Authors:  Aaron T Jacobs; Lawrence J Marnett
Journal:  J Biol Chem       Date:  2009-01-29       Impact factor: 5.157

7.  Heat shock factor Hsf1 cooperates with ErbB2 (Her2/Neu) protein to promote mammary tumorigenesis and metastasis.

Authors:  Caixia Xi; Yanzhong Hu; Phillip Buckhaults; Demetrius Moskophidis; Nahid F Mivechi
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

8.  HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.

Authors:  R Schulz; F Streller; A H Scheel; J Rüschoff; M-C Reinert; M Dobbelstein; N D Marchenko; U M Moll
Journal:  Cell Death Dis       Date:  2014-01-02       Impact factor: 8.469

9.  HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers.

Authors:  Marc L Mendillo; Sandro Santagata; Martina Koeva; George W Bell; Rong Hu; Rulla M Tamimi; Ernest Fraenkel; Tan A Ince; Luke Whitesell; Susan Lindquist
Journal:  Cell       Date:  2012-08-03       Impact factor: 41.582

10.  Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.

Authors:  Chengkai Dai; Luke Whitesell; Arlin B Rogers; Susan Lindquist
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

View more
  31 in total

1.  Heat Shock Factor 1 Epigenetically Stimulates Glutaminase-1-Dependent mTOR Activation to Promote Colorectal Carcinogenesis.

Authors:  Jiaqiu Li; Ping Song; Tingting Jiang; Dongjun Dai; Hanying Wang; Jie Sun; Liyuan Zhu; Wenxia Xu; Lifeng Feng; Vivian Y Shin; Helen Morrison; Xian Wang; Hongchuan Jin
Journal:  Mol Ther       Date:  2018-04-14       Impact factor: 11.454

2.  A pyrrole-based natural small molecule mitigates HSP90 expression in MDA-MB-231 cells and inhibits tumor angiogenesis in mice by inactivating HSF-1.

Authors:  K C Rashmi; H S Atreya; M Harsha Raj; Bharathi P Salimath; H S Aparna
Journal:  Cell Stress Chaperones       Date:  2017-07-17       Impact factor: 3.667

3.  TRIM11 cooperates with HSF1 to suppress the anti-tumor effect of proteotoxic stress drugs.

Authors:  Liang Chen; Xiaolu Yang
Journal:  Cell Cycle       Date:  2018-12-26       Impact factor: 4.534

Review 4.  Cell death in animal development.

Authors:  Piya Ghose; Shai Shaham
Journal:  Development       Date:  2020-07-24       Impact factor: 6.868

5.  The HSP90 inhibitor 17-PAG effectively inhibits the proliferation and migration of androgen-independent prostate cancer cells.

Authors:  Ruixian Peng; Zhenyu Li; Zhiyuan Lin; Yang Wang; Wei Wang; Bo Hu; Xilong Wang; Jun Zhang; Yangyun Wang; Renyuan Zhou; Chunhua Lu; Yuemao Shen; Jifeng Wang; Guowei Shi
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

6.  HSF2 regulates aerobic glycolysis by suppression of FBP1 in hepatocellular carcinoma.

Authors:  Li-Na Yang; Zhou-Yu Ning; Lai Wang; Xia Yan; Zhi-Qiang Meng
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

Review 7.  Metabolic control of the proteotoxic stress response: implications in diabetes mellitus and neurodegenerative disorders.

Authors:  Kuo-Hui Su; Chengkai Dai
Journal:  Cell Mol Life Sci       Date:  2016-06-11       Impact factor: 9.261

8.  4Ei-10 interdiction of oncogenic cap-mediated translation as therapy for non-small cell lung cancer.

Authors:  Blake A Jacobson; Zeeshan Ahmad; Sierra Chen; Gabriella Waldusky; Maxwell Dillenburg; Emilia Stoian; Daniel A Cambron; Anil J Patel; Manish R Patel; Carston R Wagner; Robert A Kratzke
Journal:  Invest New Drugs       Date:  2020-11-23       Impact factor: 3.850

9.  Mechanism of miR-455-3 in suppressing epithelial-mesenchymal transition and angiogenesis of non-small cell lung cancer cells.

Authors:  Chong Meng; Kai Liu; Xingjun Cai; Yongxing Chen
Journal:  Cell Stress Chaperones       Date:  2022-01-22       Impact factor: 3.827

10.  Repression of oncogenic cap-mediated translation by 4Ei-10 diminishes proliferation, enhances chemosensitivity and alters expression of malignancy-related proteins in mesothelioma.

Authors:  Zeeshan Ahmad; Blake A Jacobson; Mitchell W McDonald; Nicolas Vattendahl Vidal; Gabriel Vattendahl Vidal; Sierra Chen; Maxwell Dillenburg; Aniekan M Okon; Manish R Patel; Carston R Wagner; Robert A Kratzke
Journal:  Cancer Chemother Pharmacol       Date:  2020-01-23       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.